Previous Article | Next Article 
Infection and Immunity, September 1999, p. 4757-4763, Vol. 67, No. 9
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
T-Cell Responses to Treponema pallidum
subsp. pallidum Antigens during the Course of Experimental
Syphilis Infection
Thomas W.
Arroll,
Arturo
Centurion-Lara,
Sheila A.
Lukehart, and
Wesley C.
Van Voorhis*
Department of Pathobiology and Department of
Medicine, University of Washington, Seattle, Washington 98195
Received 25 February 1999/Returned for modification 5 April
1999/Accepted 7 June 1999
 |
ABSTRACT |
In this study we describe the development of the T-cell response to
a panel of Treponema pallidum antigens over the course of
syphilis infection in the rabbit and determine whether these antigens
induce the expression of Th1 cytokines. It was determined that the
membrane proteins TpN17 and TpN47, as well as the endoflagellar sheath
protein TpN37, induce strong proliferation responses through most of
syphilis infection; Tromp1 induced only weak proliferative responses.
An unexpected drop in proliferative response to these antigens at day
90 of infection, followed by a dramatic increase in response at day
180, suggests that there may be a secondary dissemination of T. pallidum which induces a recall response. Crude epitope mapping
of TpN17 and TpN37 showed that multiple epitopes may be present on both
antigens, which is likely a contributing factor in the immunodominance
of these antigens. The T-cell response to the TpN37 molecule shows
acquisition of newly recognized epitopes during the course of
infection. Sonicated T. pallidum was found to induce the
expression of interleukin-2 (IL-2) and gamma interferon and not IL-10
mRNA, showing that the general T-cell response to T. pallidum antigens in syphilis infection is biased towards the Th1
phenotype. Of the antigens tested, TpN37 appears to contribute the most
to the Th1 cytokine response and therefore may play a key role in the
clearance of T. pallidum from lesions.
 |
INTRODUCTION |
Infection with the spirochete
Treponema pallidum subsp. pallidum results in the
development of syphilis which, in untreated humans, can progress
through multiple symptomatic and latent stages. The natural history of
syphilis begins with the development of a primary lesion or chancre at
the site of infection (primary syphilis). These lesions, which contain
large numbers of treponemes, heal without antibiotic treatment. During
or following the resolution of primary syphilis, the rash of secondary
syphilis develops containing large numbers of viable T. pallidum. As in primary syphilis, these lesions will also heal
spontaneously. After the clearance of secondary lesions, a long period
of latency ensues and, in two-thirds of untreated individuals, the
infection remains latent lifelong. These clinical observations suggest
that a vigorous, but imperfect, immune response develops during
syphilis infection that is successful in clearing most but not all of
the treponemes infecting the host.
Our knowledge of the nature of the immune responses involved in lesion
clearance is far from complete. Histologic studies of human and rabbit
syphilis lesions have shown that the inflammation resembles a
delayed-type hypersensitivity response. The predominant cell types
infiltrating syphilis lesions are T lymphocytes (CD4+ and
CD8+) and macrophages (8, 24). Activated
macrophages play a major role in the clearance of T. pallidum from early syphilis lesions (19, 21).
Evidence of macrophage activation during syphilis infection was
provided by Lukehart et al. (11), who demonstrated that T. pallidum antigen-sensitized lymphocytes from syphilitic
rabbits produce macrophage-activating factors (MAFs) that stimulated
increased macrophage killing of L. monocytogenes.
Furthermore, it was shown that the peak production of MAF by
lymphocytes correlates with bacterial clearance in primary lesions of
experimentally infected rabbits (12). Although the identity
of the MAFs produced by the T. pallidum-specific lymphocytes
was not determined in that study, the cytokine gamma interferon
(IFN-
) is likely to be involved. A recent study showed that the
infiltrating cells in both primary and secondary human syphilis lesions
predominantly express the Th1 cytokines interleukin-2 (IL-2), IFN-
,
and IL-12 (23). Similar observations have been made in the
rabbit showing an increase in expression of IL-2 and IFN-
mRNA by
infiltrating cells in resolving primary syphilis lesions
(7). However, in the guinea pig model, only IL-10 synthesis
was found to be significantly stimulated after intradermal inoculation
of T. pallidum, and there was no increase in the synthesis
of IL-1
, tumor necrosis factor alpha, or IL-12 p40 (25).
These studies provide compelling evidence that one of the actions of
the T-cell response during early syphilis infection is the development
of a Th1 cytokine environment which promotes macrophage activation and
bacterial clearance. T-cell responses later in syphilis are believed to
play a role in the development of immunity to reinfection. Although
there are only limited experimental data in human syphilis, there is
evidence that partial resistance to reinfection develops after
long-term infection (17). Studies performed in rabbits are
more conclusive, showing a gradual development of resistance to
reinfection which becomes complete between 3 and 6 months postinfection
(22). Resistance is found to require cell-mediated immunity
(CMI), based on the failure of passive transfer of immune serum to
protect naive rabbits against syphilis infection (5). The
late development of immunity in the rabbit appears to be a process
separate from the bacterial clearing immune response, which develops at
13 to 17 days after infection (15). Two possible hypotheses
might explain the dichotomy of these responses: (i) the antigenic
targets of the T-cell response do not change throughout infection, but
the magnitude of the response intensifies, resulting in the development
of resistance, or (ii) the targets of the T-cell response change over
the course of infection, resulting in the development of resistance via
these newly expressed or recognized antigens.
One strategy to attempt to answer these questions about the nature and
role of T-cell responses in syphilis infection is to identify the
antigenic targets recognized by T cells throughout the course of
infection. One such study was carried out by Baker-Zander et al.
(4), who screened sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE)-fractionated T. pallidum proteins for induction of proliferation of cultured splenic lymphocytes from
infected rabbits. This study revealed that a number of previously identified proteins elicited robust T-cell-proliferative responses, namely, TpN15, TpN17, TpN30, TpN33, TpN35, TpN37, and TpN47. The identity and characteristics of these proteins is reviewed in Norris et
al. (18).
The objective of this study is to further characterize the T-cell
response to selected antigens identified in the earlier T. pallidum protein fractionation study. The membrane lipoproteins TpN17 and TpN47, as well as the endoflagellar sheath protein TpN37, were chosen for this study because they elicited the most robust T-cell
responses and they are known to possess pathogenic treponeme-specific epitopes (2, 13, 16). A previously untested protein, Tromp1, was also included in the study because it has been proposed to be an
outer membrane porin protein (6). The outer membrane location of this molecule has recently been questioned and, to this
date, Tromp1 has not been demonstrated to be a target of opsonization
(1).
In this study we describe the development of T-cell responses to a
panel of purified recombinant T. pallidum antigens over the
course of experimental syphilis infection and a shift in epitope dominance over time for some antigens. We use the rabbit model of early
syphilis because of its clear resemblance to early human syphilis
(22). Furthermore, we demonstrate the expression of Th1-type
cytokines in response to stimulation with these specific antigens.
 |
MATERIALS AND METHODS |
Rabbits.
Adult male New Zealand White rabbits were obtained
from R & R Rabbitry (Stanwood, Wash.). Rabbits were tested for evidence of Treponema paraluiscuniculi infection by the Venereal
Disease Research Laboratory (Atlanta, Ga.), fluorescent treponemal
antibody-absorbed, and Western blot tests. Only rabbits that were
seronegative by these tests were included in this study. Rabbits were
housed individually at 18 to 20°C and given antibiotic-free food and water.
Experimental infection with T. pallidum.
The Nichols
strain of T. pallidum subsp. pallidum was
propagated by serial passage in rabbits as previously described
(15). Rabbits were infected by intratesticular injection
with 108 motile T. pallidum organisms.
Cloning, expression, and purification of recombinant
proteins.
The T. pallidum Nichols strain proteins
TpN17, Tromp1, TpN37, and TpN47 were expressed as glutathione
S-transferase (GST) fusion proteins by using a PCR cloning
strategy. PCR primers were designed based on sequences published in
GenBank (Table 1). To facilitate cloning,
restriction endonuclease cleavage sites were included in all of the PCR
primers. The PCR primer pairs TpN17(full length [FL]), Tromp1(FL),
TpN37(FL), and TpN47(FL) (Table 1) were used to amplify the open
reading frames (ORFs) from purified T. pallidum genomic DNA.
The PCR reactions were performed in a 100-µl volume and contained 10 mM Tris-HCl (pH 9.0), 50 mM KCl, 200 µM deoxynucleoside triphosphates
(dNTPs), 1.5 mM MgCl, 2.5 U of Taq polymerase (Promega,
Madison, Wis.), 1 µM concentrations each of the sense and antisense
oligonucleotide primers, and 350 ng of T. pallidum genomic
DNA. The cycling conditions for all PCR reactions were 94°C for 1 min, 58°C for 1 min and 30 s, and 72°C for 1 min and 30 s. The amplicons were cut with the appropriate restriction
endonucleases and cloned into expression vectors. The Tromp1(FL)
amplicon was cloned into the vector pGex-3X (Amersham Pharmacia
Biotech, Piscataway, N.J.), and the TpN17(FL), TpN37(FL), and TpN47(FL)
amplicons were cloned into the vector pGex-5X-1 (Amersham Pharmacia
Biotech) by standard molecular techniques (20). The
TpN37(FL) and TpN47(FL) inserts, including the ORF of GST, were PCR
amplified from the resulting pGex-5X-1 clones with a GST-specific sense
primer: 5'-GAGACTCGAGTCATGTCCCCTATACTAGGT-3' and TpN37(FL)
and TpN47(FL) antisense primers by using the previously described
reaction conditions. The GST-TpN37(FL) and GST-TpN47(FL) amplicons were
also cloned into the six-histidine fusion protein vector pRSET C
(Invitrogen, San Diego, Calif.).
Truncated fragments of TpN17 and TpN37 were cloned by PCR amplification
of portions of the respective genes representing one-third
of the
coding sequence with 60-bp overlaps with the following
primer pairs:
TpN17(1/3), TpN17(2/3), TpN17(3/3), TpN37(1/3),
TpN37(2/3), and
TpN37(3/3) (Table
1). The amplicons were cut
with
BamHI and
XhoI and cloned into
BamHI/
XhoI-cut
pRSET C vector
modified by the insertion of the GST ORF of pGex-5X-1
into the
BamHI site of the
polylinker.
The plasmids GST-Tromp1(FL) and GST-17(FL) were transformed into
Escherichia coli XL-1 Blue (Stratagene, La Jolla, Calif.)
and GST-TpN37(FL), and GST-TpN47(FL) plasmids, as well as the
truncated
GST-TpN17 and GST-TpN37 plasmids, were transformed into
E. coli BL21 pLysS (Novagen, Madison, Wis.). Recombinant proteins
were expressed at 30°C in Luria-Bertani (Gibco/BRL, Grand Island,
N.Y.) broth containing 2% glucose, ampicillin (50 µg/ml), and
chloramphenicol (30 µg/ml [for BL21 pLysS hosts only]). Cultures
were induced with 0.1 mM
isopropyl-

-
D-thiogalactopyranoside (IPTG)
at an optical
density at 540 nm of 0.6 to 0.8 and incubated for
3 h. The cells
were harvested by centrifugation at 7,000 ×
g for
10 min and resuspended in lysis buffer containing 100 mM NaCl,
1 mM EDTA,
50 mM Tris (pH 8.0), aprotinin (2 µg/ml), leupeptin
(2 µg/ml), and
pepstatin (1 µg/ml) (Sigma Chemical Co., St. Louis,
Mo.). The
bacterial suspensions were frozen at

20°C and thawed,
and the cells
were disrupted by intermittent sonication on ice
for 2 min by using a
probe sonicator (Sonics Materials, Danbury,
Conn.) set to 25 W. Soluble
fusion proteins expressed by the GST-Tromp1
and GST-TpN17 clones, as
well as pGex5X-1, were purified twice
from bacterial lysates with
glutathione-agarose (Sigma) affinity
chromatography according to
manufacturer's instructions. Fusion
protein inclusion bodies produced
by the remainder of clones were
isolated as described by Harlow and
Lane (
10). The inclusion
bodies were dissolved in buffer
containing 8 M urea, 0.1 M NaH
2PO
4,
and 10 mM
Tris-HCl (pH 8.0) and centrifuged at 10,000 ×
g for
20 min to remove the insoluble material. The soluble fusion proteins
were
purified twice with Ni-NTA Superflow Resin (Qiagen, Santa
Clarita,
Calif.) according to manufacturer's instructions, dialyzed
exhaustively into 10 mM Tris-HCl (pH 8.0), quantified, and stored
at

70°C. The purity of antigens was monitored by SDS-PAGE, and
endotoxin was detected by using the
Limulus Amebocyte Lysate
Test
(BioWhittaker, Walkersville, Md.), which detects endotoxin in
excess of 0.1 endotoxin unit/ml.
Lymphocyte proliferation.
Spleens were harvested from groups
of uninfected rabbits or rabbits infected with T. pallidum
for 10, 30, 90, or 180 days. Splenic lymphocytes were cultured and
tested with antigens by using previously published protocols (4,
15). The cells were resuspended in RPMI (Gibco/BRL) containing
penicillin, streptomycin, glutamine, and 1% heat-inactivated pooled
rabbit serum and then cultured in flat-bottomed 96-well tissue culture
plates (Costar, Cambridge, Mass.) at 37°C and 5% CO2.
Optimal culture conditions and antigen concentrations for maximum
proliferative response were determined by titration (data not shown).
Quadruplicate cultures at 2.5 × 105 cells/well in 200 µl received 10 µg of concanavalin A (ConA; Sigma) per ml or
sonicated T. pallidum (107 T. pallidum/well, 6 µg of protein per ml) (15). For
recombinant antigens, quadruplicate cultures at 5 × 105 cells/well in 200 µl received 50 µg of GST, 10 µg
of GST-Tromp1, 50 µg of GST-TpN17, 5 µg of GST-TpN37, or 5 µg of
GST-TpN47 per ml. For epitope-mapping experiments the antigens were
used at 2 µg/ml for the full-length and truncated TpN17 fusion
proteins and 5 µg/ml for the full-length and truncated TpN37 fusion proteins.
Cultures containing sonicated
T. pallidum and ConA were
pulsed with 0.5 µCi of [
3H]thymidine/well on day 3 of
culture, whereas cultures containing
recombinant antigens were pulsed
on day 4 of culture. Exactly
24 h after
[
3H]thymidine addition, the cells were harvested by using
a 96-well
cell harvester (Tomtech, Orange, Conn.), and
[
3H]thymidine incorporation was measured by using an
automated liquid
scintillation counter (Betaplate 1205; Wallac, Turku,
Finland).
The data are displayed as the geometric mean of counts per
minute
minus the geometric mean of background counts per minute
measured
in control wells containing no
antigen.
Cytokine detection.
Splenic lymphocytes were cultured from
four uninfected rabbits and four rabbits each infected for 10, 30, 90, and 180 days in 1-cm-diameter-well culture plates (Costar) at a
concentration of 6.25 × 105 cells in 500 µl.
Optimal antigen concentrations and culture conditions were determined
in preliminary studies (data not shown). Each well received control or
test antigens at the concentrations listed above. The cultures were
incubated for 8 h at 37°C and 5% CO2. Cells were
pelleted by centrifugation, and RNA was isolated by using Ultraspec RNA
isolation reagent (Biotecx, Houston, Tex.) according to manufacturer's
instructions. The resulting RNA was repurified by using an RNeasy RNA
purification kit (Qiagen) according to manufacturer's instructions. To
synthesize cDNA, RNA from 3 × 105 splenocytes in 16 µl of water was incubated in the presence of 2 U of
amplification-grade DNase I (Gibco/BRL), 10 mM Tris-HCl (pH 8.4), 2 mM
MgCl2, and 50 mM KCl for 15 min at 25°C to remove contaminating genomic DNA. The reactions were stopped by the addition of 2.5 mM EDTA followed by heating at 65°C for 10 min. Random hexanucleotides (125 ng; Gibco/BRL) were added to the reactions, heated
at 70°C for 15 min, and then placed on ice. Reverse transcription (RT) was initiated by addition of 500 µM dNTPs, 10 mM dithiothreitol, 50 mM Tris-HCl (pH 8.3), 75 mM KCl, 5 mM MgCl2, 400 U of
Superscript II (Gibco/BRL), and 40 U of RNasin (Promega) and then
incubated at 43°C for 50 min. The reaction was terminated by heating
it at 70°C for 15 min. The cDNA was then quantified by hypoxanthine phosphoribosyl transferase (HPRT) competitive PCR and normalized to 2.5 fg of competitor HPRT product with an MboI 89-bp internal deletion. IFN-
, IL-2, and IL-10 signal was detected by PCR
techniques by using the oligonucleotides listed in Table
2. PCR was performed under the conditions
described above except for an initial denaturation step of 94°C for 4 min, followed by 35 cycles of 94°C for 1 min, 60°C for 2 min, and
72°C for 1 min. The resulting cytokine PCR products were quantified
by scanning ethidium bromide-stained DNA bands on agarose gels with a
UV scanner (Bio-Rad). Pixel volume data measured from PCR products were
used to calculate the DNA band concentration based on standard curves
generated by using PCR product DNA of known concentrations.
 |
RESULTS |
Fusion protein expression.
The T. pallidum proteins
of interest were expressed as fusion proteins in E. coli in
order to obtain sufficient amounts of purified protein for use in
immunologic assays. The amino terminus fusion protein partner GST was
included in all of the constructs to facilitate the expression T. pallidum proteins in E. coli and to serve as a target
for affinity purification by glutathione-agarose chromatography. The
TpN17-GST and Tromp1-GST fusion proteins were expressed as soluble
cytoplasmic proteins, which allowed purification with
glutathione-agarose (Fig. 1). The
Tromp1-GST fusion protein contained the peptide portion of the Tromp1
molecule without the signal peptide, whereas the TpN17-GST fusion
protein included the entire ORF of TpN17, including the signal peptide.

View larger version (58K):
[in this window]
[in a new window]
|
FIG. 1.
GST fusion proteins were purified by either
glutathione-agarose or nickel affinity chromatography as described in
the Materials and Methods. Ten micrograms of each protein were resolved
on an SDS-12.5% PAGE gel and stained with Coomassie blue.
|
|
The remaining proteins were expressed as fusions containing both GST
and six-histidine tags. The GST was included because
it was found in
preliminary cloning and expression experiments
that these proteins were
poorly expressed without the addition
of this fusion molecule. It was
also determined that the full-length
TpN37 and TpN47 molecules, as well
as the truncated TpN17 and
TpN37, when fused to GST were expressed as
insoluble inclusions.
Since GST does not bind to its ligand glutathione
when denatured,
the six-histidine tag was added to these constructs to
facilitate
affinity purification by nickel column chromatography under
denaturing
conditions. The TpN37-GST fusion protein contained the
entire
ORF of TpN37, and the TpN47-GST contained the mature peptide
portion
of TpN47 without the signal peptide. All of the resulting
fusion
proteins were determined to have molecular masses that matched
predicted molecular masses (Fig.
1). After two sequential purifications
by either glutathione agarose or nickel resin chromatography,
the
proteins were found to be free of measurable or mitogenic
amounts of
LPS.
Splenocyte response to T. pallidum proteins.
The
proliferative response to fusion proteins was measured over a period of
180 days of infection to monitor the T-cell response during the course
of experimental syphilis in the rabbit. The results of these time
course experiments are summarized in Fig. 2. Splenocytes from uninfected animals
showed no appreciable response to either the sonicated T. pallidum or the recombinant proteins. The response to ConA was
consistently greater than 70,000 cpm at all time points (data not
shown). The proliferative response to sonicated T. pallidum
began to develop at day 10 of infection and increased throughout the
course of the experiment, a result which mimics the response to
sonicated T. pallidum reported in previous studies (4,
15). The proliferative response to all recombinant antigens was
detectable by day 10 of infection except for the negative control GST,
which failed to induce a response at any point. The TpN17-GST and
TpN37-GST elicited the highest proliferative responses at all time
points tested, whereas TpN47-GST induced a more moderate response and
Tromp1-GST induced only a weak response. Surprisingly, the
proliferative response to all the fusion proteins dropped to baseline
levels 90 days postinfection instead of increasing as seen with the
T. pallidum sonicate. This reduction in response at day 90 was observed reproducibly in two separately infected groups of animals.
After the day-90 decline the responses to all recombinants increased to
the highest levels detected at day 180.

View larger version (33K):
[in this window]
[in a new window]
|
FIG. 2.
Splenocyte proliferative responses to T. pallidum-GST fusion proteins. Splenic lymphocytes from normal
rabbits (day 0) (n = 9) and from rabbits infected with
T. pallidum for 10 (n = 11), 30 (n = 8), 90 (n = 8), or 180 (n = 4) days were tested for
proliferative responses to the panel of recombinant T. pallidum antigens. The data points represent the geometric means
of the proliferative measurements of each group of rabbits ± the
standard error of the mean (SEM). The background proliferative response
(no antigen) for each condition was less than 2,500 cpm. Data from at
least two groups of infected rabbits are shown for each time point
except for day 180, which is from one group of infected rabbits.
|
|
Epitope mapping of TpN17 and TpN37 proteins.
Because the
proliferative response to TpN17-GST and TpN37-GST was so prominent, we
were interested in examining the number of T-cell epitopes recognized
on these molecules and determining whether there is a shift or spread
of the epitopes recognized over the course of infection. Because
outbred animals were used for these experiments, we chose to perform a
crude epitope-mapping study in which we examined proliferative
responses to one-third-length fragments of the antigens of interest.
The antigen fragments were expressed as GST fusion proteins and tested
for splenocyte proliferative activity in animals infected with T. pallidum for 10, 30, or 180 days. The responses to the TpN17
fragments showed splenocyte proliferation to TpN17(2/3)-GST and
TpN17(3/3)-GST by day 30 of infection (Fig. 3). The response to these two fragments
peaked at day 180, with TpN17(3/3)-GST showing the highest response.
The TpN17(1/3)-GST failed to elicit an appreciable proliferative
response at any of the time points tested. The proliferative response
to the TpN37 fragments showed a markedly different pattern compared to
that of the TpN17 fragments. A response to TpN37(2/3)-GST was present by day 10 of infection with no appreciable response to the flanking fragments. By day 180 the maximum response was directed to
TpN37(3/3)-GST, with TpN37(2/3)-GST and TpN37(1/3)-GST showing
appreciable but lower responses.

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 3.
Mapping of epitopes recognized by splenic lymphocytes.
Truncated fragments of TpN17 and TpN37 expressed as GST fusion proteins
were tested for proliferative responses in splenic lymphocytes from
normal rabbits (day 0) and a group of rabbits infected with T. pallidum for 10, 30, and 180 days (n = 4 for each
time point). The data points represent the geometric means of the
proliferation measurements of each group of rabbits ± the SEM.
|
|
Cytokine expression in response to T. pallidum
antigens.
mRNA coding for the cytokines IL-2, IL-10, and IFN-
was measured by RT-PCR in splenocytes incubated with T. pallidum antigens. The goal of these experiments was to determine
whether the antigens under investigation are involved in eliciting the
Th1 response detected in resolving syphilis lesions (7). The
cytokines IL-2 and IFN-
were studied because they are indicators of
Th1 response, whereas IL-10 served as an indicator of a Th2 response or
the presence of macrophages. Splenocytes cultured with sonicated
T. pallidum produced IFN-
mRNA as early as 10 days after
infection (Fig. 4). IFN-
mRNA
expression increased at day 30, was reduced to baseline at day 90, and
peaked at day 180. The responses to the recombinant T. pallidum proteins showed a similar temporal pattern of IFN-
mRNA expression. This bimodal pattern of IFN-
mRNA expression mimics
the proliferative response to the recombinant antigens (Fig. 2).
Generally, the magnitude of the IFN-
mRNA expression correlates with
the magnitude of proliferation for a given recombinant protein. One
exception to this is the IFN-
mRNA expression in response to
TpN17-GST, which is notably lower than the response to TpN37-GST (Fig.
4) despite the fact that the proliferative responses are nearly
identical (Fig. 2).

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 4.
IFN- mRNA expression in response to T. pallidum-GST fusion proteins. Total RNA was isolated from
splenocytes cultured with antigen; IFN- message was measured by
RT-PCR. Data points represent the means ± the SEM of values
measured in groups of four animals infected at the same time for all
time points except day 30 (three rabbits).
|
|
The IL-2 mRNA expression induced by the sonicated
T. pallidum closely resembles the proliferative response, showing a
generally
increasing trend beginning at day 10 and peaking at day 180 (Fig.
5). The responses to the
recombinant proteins were considerably
different, the peak response
occurring at day 10, with a subsequent
downregulation over time toward
day 90. The IL-2 mRNA expression
increased again at day 180 but to a
lower level than at day 10.
There were no appreciable changes in the
expression of IL-10 mRNA
between the control and
T. pallidum-infected animals at days 10,
30, 90, or 180 after
infection with all the antigens tested (data
not shown).

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 5.
IL-2 mRNA expression in response to T. pallidum-GST fusion proteins. Total RNA was isolated from
splenocytes cultured with antigens; IL-2 message was measured by
RT-PCR. Data points represent the means ± the SEM of values
measured in groups of four animals infected at the same time for all
time points except day 30 (three rabbits).
|
|
 |
DISCUSSION |
The T-cell response associated with healing T. pallidum
lesions in both humans and rabbits produces a Th1 predominant cytokine pattern (7, 23). T. pallidum-specific T cells can
be detected as early as 6 days after infection in the rabbit and are
found at peak levels during clearance of bacteria from lesions
(15). A number of major T-cell antigens have been identified
by screening fractionated T. pallidum proteins, including
TpN17, TpN37, and TpN47 (4). These proteins have been
determined by SDS-PAGE fractionation to be major components of T. pallidum (13). The current study demonstrates that
recombinant TpN17, TpN37, and TpN47 antigens induce a robust T-cell
response, thus confirming the observations of Baker-Zander et al.
(4). By using affinity-purified recombinant proteins we were
able to determine with a higher degree of certainty that the
proliferative responses observed were induced by the target molecules
and not by trace proteins contaminants, as can occur with proteins
isolated directly from T. pallidum. The proliferative
responses to the recombinant antigens, like that of sonicated T. pallidum, were detectable by day 10 of infection and increased
appreciably by day 30. This pattern of T-cell response development
corresponds with the clearance of the majority of T. pallidum from primary lesions (14). This temporal
correlation suggests that the robust T-cell responses to TpN17, TpN37,
and TpN47 may be involved in the clearance of bacteria.
The decrease in the proliferative responses to the recombinant antigens
at day 90 of infection was not expected, based on earlier observations
that the response to sonicated T. pallidum is maintained at
high levels in infected rabbits for as long as 2 years (15).
One possible explanation for this finding is that the reduction in
response to individual antigens is a normal downregulation of the
T-cell response which occurs as a result of the clearance of the
majority of T. pallidum from the host. Why this day 90 downregulation is not seen in the response to sonicated T. pallidum is uncertain, but it can be reasoned that, because the
sonicate contains a complex mixture of proteins, it is possible that a late T-cell response to a separate subset of antigens masks the downregulation observed with the TpN17, TpN37, and TpN47 antigens.
The reappearance of the proliferative responses to the recombinant
antigens at day 180 raises further questions. The proliferative responses to the recombinant antigens and sonicated T. pallidum reached peak levels at day 180, suggesting a recall
response. In order for a recall response to be initiated, antigenic
restimulation must occur. The source of this putative secondary
antigenic stimulation can only be speculated upon at this point, but
one logical hypothesis is that there is a reactivation of T. pallidum dissemination at some point between 90 and 180 days.
Secondary dissemination of T. pallidum does occur in humans
at this time and causes the secondary rash of syphilis, but no clinical
signs of secondary syphilis are usually observed in experimentally
infected rabbits, and the reactivation may be subclinical. The
existence of bimodal T-cell responses to individual antigens in
syphilis infections has been reported previously. The study of
Baker-Zander et al. (4) showed that the T-cell response to
TpN47 and a complex containing the two flagellar proteins TpN33 and
TpN35 is reduced to baseline at day 30 of infection and then increase
dramatically at day 210. Splenocytes from day 90-infected rabbits were
not tested in these experiments, but nevertheless there appears to be a
comparable downregulation followed by a recall response. In a separate
study, Baker-Zander and Sell (3) showed a drop in the
splenic and lymph node lymphocyte response to sonicated T. pallidum at day 90 of infection, followed by a secondary peak at
day 180. Furthermore, it was shown that the splenocyte response
declined again at 12 months of infection and resurged at 24 months.
The possibility that the multiphasic T-cell responses observed in this
and previous studies are the result of periodic T. pallidum
bacteremia is intriguing but difficult to test experimentally. The
difficulty in detecting T. pallidum has hampered efforts to monitor asymptomatic infection. Although there have been many detailed
studies monitoring T. pallidum in lesions and organ tissues over the course of early syphilis in the rabbit, there have only been
limited studies investigating the numbers of T. pallidum present in latent infection (3, 9, 22). The question of whether T. pallidum is periodically reactivated in rabbits
could be answered by monitoring for the presence of T. pallidum DNA in blood or other tissues by PCR amplification. If
there are in fact waves of asymptomatic T. pallidum
bacteremia in the rabbit, this would provide valuable insight into the
immune evasion strategies utilized by this pathogen. Antigenic
variation of outer membrane proteins, as seen in African trypanosomes
and many Borrelia species, has long been suspected in
T. pallidum but no variable outer-membrane-expressed antigens have been identified to date.
Because TpN17 and TpN37 elicited the strongest T-cell responses
observed in this study, we were interested in determining whether these
antigens possess multiple T-cell epitopes and whether there might be a
shift or spreading of epitope recognition during the course of
infection. The epitope-mapping studies showed that multiple epitopes
are recognized on TpN17 and TpN37. It is possible that some of the
proliferative responses were directed to the 20-amino-acid overlap
included in the truncated fragments, so there may be as few as one
T-cell epitope on TpN17 and as few as two T-cell epitopes on TpN37;
alternatively, there may be several epitopes on each stimulatory
fragment. The recognition of multiple epitopes on these molecules is
likely to be one factor that contributes to the immunodominance of
these two molecules. Antigenic spreading was observed in the response
to TpN37, showing an initial predominant response to the central
portion of the molecule followed by the development of responses to the
first and third fragments of the proteins later in infection. This
shows that an initial focused proliferative response can be detected to
an immunodominant portion of TpN37, even in outbred rabbits. The
functional significance of this epitope spreading has yet to be
determined, but it is possible that the late-developing response to
epitopes may contribute to the immunity to reinfection that becomes
complete by day 90.
After characterizing the proliferative responses to this panel of
proteins, we were interested in assessing the functional significance
of these T-cell responses by measuring IFN-
, IL-2, and IL-10 mRNA
synthesis in response to the individual antigens. The expression of
IFN-
and IL-2 mRNA generally followed the patterns of proliferation,
with production during the first 30 days of infection, a reduction
between 30 and 90 days, and a secondary increase at day 180. This
pattern of response provides additional evidence for the existence of a
recall response, possibly induced by a secondary T. pallidum
bacteremia. The induction of IL-2 and IFN-
mRNA and the lack of
induction of IL-10 by sonicated T. pallidum shows that the
T-cell responses generated during syphilis infection are biased toward
the Th1 phenotype. Lacking information on IL-4 expression, we cannot
formally exclude the existence of a Th2-type response. Of the antigens
tested, TpN37 appears to have the greatest influence on the development
of the Th1-type T-cell response, showing the strongest induction of
both IFN-
and IL-2 mRNA. The intensity of the proliferation and Th1
cytokine response to the TpN37 correlates with both lesion-clearing
response (days 10 to 30) and resistance to reinfection (day 180). Thus, TpN37 merits further investigation as a CMI-inducing component of a
multivalent vaccine for syphilis.
 |
ACKNOWLEDGMENTS |
We thank Anna Dukes, Lynn Barrett, and Christa Castro for their
enthusiastic assistance with this project.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: University of
Washington, P.O. Box 357185, Seattle, WA 98195. Phone: (206) 543-0821. Fax: (206) 685-8681. E-mail: wesley{at}u.washington.edu.
Editor:
D. L. Burns
 |
REFERENCES |
| 1.
|
Akins, D. R.,
E. Robinson,
D. Shevchenko,
C. Elkins,
D. L. Cox, and J. D. Radolf.
1997.
Tromp1, a putative rare outer membrane protein, is anchored by an uncleaved signal sequence to the Treponema pallidum cytoplasmic membrane.
J. Bacteriol.
179:5076-5086[Abstract/Free Full Text].
|
| 2.
|
Bailey, M. J.,
A. Cockayne, and C. W. Penn.
1987.
Production of murine monoclonal antibodies to the major axial filament polypeptide of Treponema pallidum.
J. Gen. Microbiol.
133:1805-1813[Abstract/Free Full Text].
|
| 3.
|
Baker-Zander, S., and S. Sell.
1980.
A histopathologic and immunologic study of the course of syphilis in the experimentally infected rabbit. Demonstration of long-lasting cellular immunity.
Am. J. Pathol.
101:387-413[Abstract].
|
| 4.
|
Baker-Zander, S. A.,
M. J. Fohn, and S. A. Lukehart.
1988.
Development of cellular immunity to individual soluble antigens of Treponema pallidum during experimental syphilis.
J. Immunol.
141:4363-4369[Abstract].
|
| 5.
|
Bishop, N. H., and J. N. Miller.
1976.
Humoral immunity in experimental syphilis. I. The demonstration of resistance conferred by passive immunization.
J. Immunol.
117:191-196[Abstract/Free Full Text].
|
| 6.
|
Blanco, D. R.,
C. I. Champion,
M. M. Exner,
E. S. Shang,
J. T. Skare,
R. E. Hancock,
J. N. Miller, and M. A. Lovett.
1996.
Recombinant Treponema pallidum rare outer membrane protein 1 (Tromp1) expressed in Escherichia coli has porin activity and surface antigenic exposure.
J. Bacteriol.
178:6685-6692[Abstract/Free Full Text].
|
| 7.
| Centurion-Lara, A., C. Castro, A. Dukes, and S. A. Lukehart. Cytokine expression in chancres of experimental
syphilis. Submitted for publication.
|
| 8.
|
Engelkens, H. J.,
F. J. ten Kate,
J. Judanarso,
V. D. Vuzevski,
J. B. van Lier,
J. C. Godschalk,
J. J. van der Sluis, and E. Stolz.
1993.
The localisation of treponemes and characterisation of the inflammatory infiltrate in skin biopsies from patients with primary or secondary syphilis, or early infectious yaws [published erratum appears in Genitourin Med 1993 Aug;69(4):327].
Genitourin. Med.
69:102-107[Medline]. (Erratum, 69:327.)
|
| 9.
|
Frazier, C. N.,
A. Bensal, and C. S. Keuper.
1952.
Further observations on the duration of spirochetemia in rabbits with asymptomatic syphilis.
Am. J. Syphilis
36:167-173.
|
| 10.
|
Harlow, E., and D. Lane.
1988.
Antibodies: a laboratory manual.
Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 11.
|
Lukehart, S. A.
1982.
Activation of macrophages by products of lymphocytes from normal and syphilitic rabbits.
Infect. Immun.
37:64-69[Abstract/Free Full Text].
|
| 12.
|
Lukehart, S. A.
1992.
Immunology and pathogenesis of syphilis, p. 141-163.
In
T. C. Quinn (ed.), Sexually transmitted diseases, vol. 8. Raven Press, Ltd., New York, N.Y.
|
| 13.
|
Lukehart, S. A.,
S. A. Baker-Zander, and E. R. Gubish, Jr.
1982.
Identification of Treponema pallidum antigens: comparison with a nonpathogenic treponeme.
J. Immunol.
129:833-838[Abstract].
|
| 14.
|
Lukehart, S. A.,
S. A. Baker-Zander,
R. M. Lloyd, and S. Sell.
1980.
Characterization of lymphocyte responsiveness in early experimental syphilis. II. Nature of cellular infiltration and Treponema pallidum distribution in testicular lesions.
J. Immunol.
124:461-467[Abstract].
|
| 15.
|
Lukehart, S. A.,
S. A. Baker-Zander, and S. Sell.
1980.
Characterization of lymphocyte responsiveness in early experimental syphilis. I. In vitro response to mitogens and Treponema pallidum antigens.
J. Immunol.
124:454-460[Abstract].
|
| 16.
|
Lukehart, S. A.,
M. R. Tam,
J. Hom,
S. A. Baker-Zander,
K. K. Holmes, and R. C. Nowinski.
1985.
Characterization of monoclonal antibodies to Treponema pallidum.
J. Immunol.
134:585-592[Abstract].
|
| 17.
|
Magnuson, H. J.,
D. D. Thomas,
S. Olansky,
B. I. Kaplan,
L. DeMello, and J. C. Cutler.
1956.
Inoculation of syphilis in human volunteers.
Medicine
35:33-82.
|
| 18.
|
Norris, S. J.,
J. F. Alderete,
N. H. Axelsen,
M. J. Bailey,
S. A. Baker-Zander,
J. B. Baseman,
P. J. Bassford,
R. E. Baughn,
A. Cockayne,
P. A. Hanff,
P. Hindersson,
S. A. Larsen,
M. A. Lovett,
S. A. Lukehart,
J. N. Miller,
M. M. A.,
F. Muller,
M. V. Norgard,
C. W. Penn,
L. V. Stamm,
J. D. van Emden, and K. Wicher.
1987.
Identity of Treponema pallidum subsp. pallidum polypeptides: correlation of sodium dodecyl sulfate-polyacrylamide gel electrophoresis results from different laboratories.
Electrophoresis
8:77-92.
|
| 19.
|
Ovcinnikov, N. M., and V. V. Delektorskij.
1972.
Electron microscopy of phagocytosis in syphilis and yaws.
Br. J. Vener. Dis.
48:224-248.
|
| 20.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 21.
|
Sell, S.,
S. Baker-Zander, and H. C. Powell.
1982.
Experimental syphilitic orchitis in rabbits: ultrastructural appearance of Treponema pallidum during phagocytosis and dissolution by macrophages in vivo.
Lab. Invest.
46:355-364[Medline].
|
| 22.
|
Turner, T. B., and D. H. Hollander.
1957.
Biology of the treponematoses.
World Health Organization, Geneva, Switzerland.
|
| 23.
|
Van Voorhis, W. C.,
L. K. Barrett,
D. M. Koelle,
J. M. Nasio,
F. A. Plummer, and S. A. Lukehart.
1996.
Primary and secondary syphilis lesions contain mRNA for Th1 cytokines.
J. Infect. Dis.
173:491-5[Medline].
|
| 24.
|
Van Voorhis, W. C.,
L. K. Barrett,
J. M. Nasio,
F. A. Plummer, and S. A. Lukehart.
1996.
Lesions of primary and secondary syphilis contain activated cytolytic T cells.
Infect. Immun.
64:1048-1050[Abstract].
|
| 25.
|
Wicher, V.,
A. M. Scarozza,
A. I. Ramsingh, and K. Wicher.
1998.
Cytokine gene expression in skin of susceptible guinea pig infected with Treponema pallidum.
Immunology
95:242-247[Medline].
|
Infection and Immunity, September 1999, p. 4757-4763, Vol. 67, No. 9
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Leader, B. T., Godornes, C., VanVoorhis, W. C., Lukehart, S. A.
(2007). CD4+ Lymphocytes and Gamma Interferon Predominate in Local Immune Responses in Early Experimental Syphilis. Infect. Immun.
75: 3021-3026
[Abstract]
[Full Text]
-
LaFond, R. E., Lukehart, S. A.
(2006). Biological Basis for Syphilis. Clin. Microbiol. Rev.
19: 29-49
[Abstract]
[Full Text]
-
Giacani, L., Sun, E. S., Hevner, K., Molini, B. J., Van Voorhis, W. C., Lukehart, S. A., Centurion-Lara, A.
(2004). Tpr Homologs in Treponema paraluiscuniculi Cuniculi A Strain. Infect. Immun.
72: 6561-6576
[Abstract]
[Full Text]
-
Morgan, C. A., Lukehart, S. A., Van Voorhis, W. C.
(2002). Immunization with the N-Terminal Portion of Treponema pallidum Repeat Protein K Attenuates Syphilitic Lesion Development in the Rabbit Model. Infect. Immun.
70: 6811-6816
[Abstract]
[Full Text]
-
Morgan, C. A., Molini, B. J., Lukehart, S. A., Van Voorhis, W. C.
(2002). Segregation of B and T Cell Epitopes of Treponema pallidum Repeat Protein K to Variable and Conserved Regions During Experimental Syphilis Infection. J. Immunol.
169: 952-957
[Abstract]
[Full Text]
-
Panelius, J., Lahdenne, P., Saxen, H., Heikkila, T., Seppala, I.
(2001). Recombinant Flagellin A Proteins from Borrelia burgdorferi Sensu Stricto, B. afzelii, and B. garinii in Serodiagnosis of Lyme Borreliosis. J. Clin. Microbiol.
39: 4013-4019
[Abstract]
[Full Text]